Constellation Brands, Inc. (NYSE: STZ) is ending 2025 the way it spent much of the year: as one of the market’s most debated “defensive” stocks.
On December 23, 2025, STZ was trading around $141.74, a level that reflects a sharp rebound from the mid-$130s area and puts the beer, wine, and spirits giant back in the spotlight for momentum traders and long-term investors alike.
The big question behind today’s move is the same one that’s been haunting the stock for months: Is Constellation Brands stock in a real turnaround—or just bouncing because it got too cheap and too hated?
What’s happening with Constellation Brands stock on Dec. 23, 2025
STZ’s latest price action is notable because it comes after a bruising stretch where investors repeatedly repriced the company’s near-term growth outlook. Market data shows STZ recently traded near $141.74 after sitting closer to $135 late last week, with market commentary describing the jump as a roughly 5% move on heavy attention.
It’s also the kind of move that tends to attract “secondary” headlines—routine but still informative signals about positioning. On Dec. 23, a MarketBeat filing-focused report flagged that Coho Partners Ltd. cut its position in Constellation Brands. That doesn’t automatically translate to a fundamental call (institutions rebalance for dozens of reasons), but it adds to the sense that big holders have been actively reshuffling exposure around STZ’s slide and rebound. MarketBeat
Meanwhile, a same-day analysis piece from Simply Wall St put the spotlight on a different angle: free cash flow. Their thesis is basically that even with demand and policy headwinds, Constellation’s beer portfolio can still generate meaningful cash that supports dividends and investment—making cash generation, not revenue growth, the near-term “scoreboard” for the stock. Simply Wall St
The real driver: 2025 turned into a “consumer stress test” for STZ
Constellation Brands is a classic American paradox in a can: it sells premium-ish products that often behave like staples… until they don’t.
Across 2025, management commentary and external reporting converged on one core theme: consumer demand softened, with particular pressure tied to Constellation’s large Hispanic consumer base in beer. The Associated Press reported that Constellation lowered its full-year sales and earnings forecasts amid weaker demand, noting that Hispanic customers represent about half of its business and that the company cited factors like rising prices, job-market worries, and immigration-related concerns weighing on discretionary spending.
That backdrop isn’t just a media narrative—it also showed up in analyst research. Jefferies downgraded Constellation Brands to Hold from Buy in a note published Dec. 17, 2025, cutting its price target to $154 (from $170) and arguing it had underestimated the duration of demand headwinds. The note pointed to survey data suggesting immigration enforcement concerns were changing behavior in ways that could reduce away-from-home activities, which matters for beer sales and social occasions.
Constellation Brands’ latest outlook: the company itself reset expectations
To understand STZ today, you have to separate what Constellation’s brands are doing in the market from what its financial statements look like while it restructures and divests.
September 2025: outlook cut and demand headwinds made official
In a Sept. 2, 2025 update, Constellation reduced its fiscal 2026 expectations. Highlights included:
- Comparable EPS guidance: $11.30–$11.60
- Enterprise organic net sales: expected to decline (6)% to (4)%
- Beer net sales: expected to decline (4)% to (2)%
- Wine & Spirits organic net sales: expected to decline (20)% to (17)% (unchanged in that update)
This matters for investors because it reframed STZ’s near-term story from “premium beer compounder” to “high-quality franchise navigating a demand air pocket.”
October 2025: Q2 FY26 results reinforced the cash-flow focus
In its Q2 FY26 materials filed with the SEC, Constellation said it was operating in a “challenging socioeconomic environment” and updated fiscal 2026 reported EPS outlook to $9.86–$10.16, while affirming comparable EPS outlook of $11.30–$11.60. It also reiterated targets for operating cash flow of $2.5–$2.6 billion and free cash flow of $1.3–$1.4 billion. Securities and Exchange Commission
That same disclosure also emphasized ongoing capital returns, including $604 million of share repurchases through September 2025, and a $1.02 quarterly cash dividend.
In other words: even as growth slowed, the company wanted investors watching cash generation and shareholder returns as the stabilizers.
Wine and spirits: Constellation’s portfolio surgery is real—and visible
STZ isn’t just a beer stock with extra baggage. Management has been actively reshaping the wine business.
Constellation closed a transaction with The Wine Group on June 2, 2025 to divest primarily mainstream wine brands and related assets. Brands divested included Woodbridge, Meiomi, Robert Mondavi Private Selection, Cook’s, SIMI, and J. Rogét sparkling wine, among other associated inventory, facilities, and vineyards.
Strategically, Constellation has framed this as a pivot toward a portfolio of higher-growth, higher-margin brands (especially in wine and spirits), rather than fighting a broader mainstream wine slowdown with scale alone.
Cost savings and restructuring: the $200M+ question
When a consumer company loses its “easy growth” narrative, it usually tries to buy time with efficiency. Constellation is doing exactly that.
In its communications around the wine/spirit repositioning, Constellation said an organizational review is expected to deliver net annualized cost savings in excess of $200 million by fiscal 2028, with the majority of the work expected to be completed by fiscal 2026.
This is one of the most important “bridge” variables for STZ bulls: if demand stays soft, cost savings can protect margins and free cash flow while the company waits for better conditions.
Capital markets moves: debt management and a big “resale registration” headline
$500M senior notes due 2035
Constellation priced a public offering of $500 million of 4.950% Senior Notes due 2035 at 99.716% of principal in October 2025. The company said it intended to use proceeds for general corporate purposes including redeeming its outstanding 4.400% Senior Notes due 2025 (also $500 million principal).
That’s not flashy, but it’s a classic playbook move: extend maturities and keep flexibility while navigating a choppy demand environment.
Shelf registration + resale of 21.27M shares (important nuance)
A headline that spooked some readers in November: Constellation filed a Form S-3 shelf registration and also filed a prospectus supplement registering the resale of up to 21,274,829 shares of Class A stock.
Here’s the key nuance straight from the 8-K: the company said it will not receive proceeds from any sale of shares by the selling stockholders. In plain English, it’s a mechanism to allow certain holders to sell registered shares—not necessarily a new issuance by the company.
Analyst forecasts and price targets: Wall Street is split, but the calendar is clear
Even after multiple estimate resets in 2025, sell-side forecasts still imply that STZ’s next big “truth moment” is close.
Next earnings date: January 7, 2026
Constellation plans to report third-quarter FY2026 results (quarter ended Nov. 30, 2025) on Jan. 7, 2026 after market close, with a conference call scheduled for Jan. 8, 2026 at 10:30 a.m. ET.
What analysts expect for the quarter
Zacks’ detailed estimates page shows a consensus EPS estimate of $2.66 for the quarter ending November 2025, with FY2026 EPS at $11.50 and FY2027 EPS at $12.45.
That’s broadly consistent with the company’s comparable EPS guidance range (which remains a key anchor for the investment debate).
Price targets: wide dispersion
Aggregators show a broad spread in price targets and ratings—typical for a stock transitioning from “growth certainty” to “prove-it phase.”
- MarketWatch lists an average price target around $168.45 with a “Moderate Buy” style consensus snapshot. MarketWatch
- MarketBeat shows an average target around $181.96 (with highs reaching well above $200 and lows closer to the low $100s).
- Jefferies is now at Hold with $154.
This dispersion is the market telling you something: investors don’t just disagree on the multiple—they disagree on the trajectory.
Why STZ is bouncing now: the most plausible explanations
No single headline neatly explains STZ’s rebound. But the most defensible explanation is a cocktail (yes, pun unavoidable) of three forces:
- Positioning + mean reversion: After a steep decline, investors often test whether bad news is already priced in—especially in Consumer Staples names that can look “cheap” on historical multiples. Jefferies itself acknowledged STZ was trading at a lower valuation versus its long-term history even as it argued fundamentals didn’t yet support an inflection. Investing.com
- Cash-flow framing: Commentary like Simply Wall St’s Dec. 23 piece highlights why some investors can tolerate weak sales prints if free cash flow holds up and dividends remain secure.
- Earnings timing: With the next report date now clearly marked for early January, the stock can move on expectations-setting alone—particularly if investors think management may “kitchen sink” bad news again, or conversely signal stabilization. Constellation Brands, Inc.+1
The catalysts investors will watch into January 2026
If you’re following Constellation Brands stock into the Q3 FY26 print, these are the datapoints most likely to move STZ:
- Beer demand and depletions trends: Are Modelo/Corona/Pacifico stabilizing in high-frequency channel data? (Management has repeatedly emphasized competitive performance even in a weak environment.)
- Hispanic consumer behavior signals: Both company commentary and analyst notes have highlighted sensitivity here; any sign of easing pressure could re-rate the stock.
- Tariff and trade policy risk: Constellation itself has cited tariffs as a factor affecting outlook, and external coverage has tied beer guidance cuts to tariff exposure.
- Progress on cost savings: The promised $200M+ annualized savings by FY2028 is a long runway, but investors will look for evidence that it’s becoming real, not just PowerPoint-real.
- Capital returns: Buybacks and the dividend are central to the “cash-flow resilience” bull case. Securities and Exchange Commission+1
Bottom line: STZ is a “quality franchise” stock in a “prove it” market
Constellation Brands still owns some of the most powerful beer brands in the U.S. import ecosystem, and it’s reshaping its wine portfolio while leaning hard on free cash flow, buybacks, and a dividend to keep investors engaged.
But Wall Street’s posture going into 2026 is cautious for a reason: multiple sources—company guidance, mainstream reporting, and sell-side analysis—agree that consumer demand has been uneven, and that the hoped-for inflection in fundamentals hasn’t yet arrived clearly enough to end the debate.
January’s earnings report won’t answer everything, but it’s the next major checkpoint for whether Constellation Brands stock is building a floor—or just taking a breather between downdrafts.
